ArticleOncoTargets and therapy2022

Efficacy and Safety of Pyrotinib in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Multicenter, Retrospective, Real-World Study.

Xiaoling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.